Company Manuka, Inc.

Equities

MNKA

US04302Q1094

Biotechnology & Medical Research

Market Closed - OTC Markets 12:45:10 2024-05-09 pm EDT 5-day change 1st Jan Change
0.03 USD -25.00% Intraday chart for Manuka, Inc. -25.00% -58.33%

Business Summary

Manuka, Inc., formerly Artemis Therapeutics, Inc., is focused on offering facial skincare products based on Manuka honey and bee venom. The Company’s products include Face Serum with Manuka Honey and Bee Venom, Face Serum with Enhanced Vitamin C, Day Cream, Nourishing Night Cream with Manuka Honey and Nee Venom, Eye Cream with Manuka Honey and Bee Venom, Face Cleanser Gel and Face Serum. Its Face Serum with Manuka Honey and Bee Venom supports blurring and reduces skin wrinkles. It regenerates skin cells and gives a young and vital appearance to the skin. The bee venom encourages natural skin revival, boosts production of Collagen, enhances skin elasticity and has healing properties for damages skin cells.

Number of employees: 4

Managers

Managers TitleAgeSince
Chief Executive Officer 70 22-06-29
Director of Finance/CFO 60 22-07-25
Chief Tech/Sci/R&D Officer 66 16-08-01
Chief Operating Officer 76 19-12-31

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 70 22-06-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 112,033,909 14,484,776 ( 12.93 %) 0 12.93 %

Shareholders

NameEquities%Valuation
80,729,883 72.06 % 3 M $
Chomsky Adler Marketing Communication Ltd.
11.26 %
12,614,868 11.26 % 504 595 $
Eyal Chomsky Holdings Ltd.
3.753 %
4,204,382 3.753 % 168 175 $

Company contact information

Manuka, Inc.

18 East 16th Street Suite 307

10003, New York

+

http://www.artemis-therapeutics.com
address Manuka, Inc.(MNKA)
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW